Interpretability of multimodal neural networks for prediction of visual acuity in patients with branch retinal vein occlusion
Summary
This retrospective proof-of-concept study developed multimodal neural networks to predict 12-month best-corrected visual acuity (BCVA) classes in treatment-naive branch retinal vein occlusion (BRVO) eyes. The best internal model integrated OCT-horizontal scans, OCTA images, baseline BCVA, central subfield thickness, age, and sex. Researchers evaluated performance using adjacent accuracy, exact accuracy, and mean absolute error under five-fold cross-validation, analyzing attribution localization with Pathway Attribution. A supplementary exploratory cross-disease feasibility analysis was also conducted using a diabetic macular edema (DME) OCT cohort with 24-month visual acuity outcomes. While results suggest multimodal imaging and clinical metadata may provide complementary prognostic information for BRVO, the study emphasizes cautious interpretation due to modest predictive performance, its retrospective single-center design, lack of disease-matched external validation, and limited attribution reliability, calling for prospective validation.
Key takeaway
For AI Scientists developing clinical prediction models, you should prioritize prospective, multi-center validation for multimodal neural networks before clinical deployment. Your models, even with interpretability features like Pathway Attribution, require robust external validation to overcome limitations of retrospective, single-center designs. Focus on improving predictive performance beyond modest levels to ensure clinical utility and reliability.
Key insights
Multimodal neural networks can predict 12-month BCVA in BRVO, but require rigorous validation.
Principles
- Multimodal data offers complementary prognostic information.
- Attribution localization aids model interpretability.
- Retrospective studies need prospective validation.
Method
Developed multimodal neural networks to predict 12-month BCVA classes using retinal images and clinical metadata, evaluated via five-fold cross-validation and Pathway Attribution.
In practice
- Combine OCT scans, OCTA, and clinical data for prognosis.
- Use Pathway Attribution for model interpretability.
- Plan prospective studies for clinical validation.
Topics
- Multimodal Neural Networks
- Visual Acuity Prediction
- Branch Retinal Vein Occlusion
- Optical Coherence Tomography
- Explainable AI
- Clinical Prognosis
Best for: AI Scientist, Research Scientist, Machine Learning Engineer
Related on AIssential
Editorial summary, takeaway, and curation by AIssential. Original article published by Machine learning : nature.com subject feeds.